Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Sangamo BioSciences

Sangamo BioSciences reported $80.09M in EBITDA for its fiscal quarter ending in March of 2023.

Ebitda Change
Alaunos Therapeutics Inc ZIOP:US USD -8976000 1.15M
Alnylam Pharmaceuticals ALNY:US USD -135742000 38.56M
Amgen AMGN:US USD 3B 42M
Bayer BAYN:GR EUR 4.47B 1.31B
Biogen BIIB:US USD 686.7M 312.1M
BioMarin Pharmaceutical BMRN:US USD 87.87M 87.82M
Bluebird Bio BLUE:US USD -83411000 8.1M
Gilead Sciences GILD:US USD 2.24B 456M
GlaxoSmithKline GSK:LN GBP 2.56B 960M
Intercept Pharmaceuticals ICPT:US USD -31543000 13.66M
Ionis Pharmaceuticals IONS:US USD -110937000 93.44M
J&J JNJ:US USD 9B 934.8M
Novartis NOVN:VX USD 4.72B 217M
Pfizer PFE:US USD 8.01B 683M
Roche Holding ROG:VX CHF 10.43B 3B
Sangamo BioSciences SGMO:US USD 80.09M 132.14M
Sarepta Therapeutics SRPT:US USD -126783000 30.5M
Ultragenyx Pharmaceutical RARE:US USD -148869000 8.2M
Vertex Pharmaceuticals VRTX:US USD 817.8M 254.1M